2003
DOI: 10.1016/s0165-5728(03)00007-9
|View full text |Cite
|
Sign up to set email alerts
|

CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
32
0
1

Year Published

2004
2004
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(36 citation statements)
references
References 52 publications
3
32
0
1
Order By: Relevance
“…All primary CD34 þ CML cells were clearly shown to be TrkA positive (Figure 8b). In agreement with previous work (Bracci-Laudiero et al, 2003), CD34 þ cells from peripheral blood from healthy donors were stained weakly by TrkA-specific antibody (data not shown). We then performed a colony-forming assay in the presence of interleukin-3 (10 ng/ml) and granulocyte-macrophage colony-stimulating factor (20 ng/ml) with and without imatinib and/or NGF (50 or 200 ng/ml).…”
Section: Abl Tyrosine Kinase Downmodulates Trka Signalingsupporting
confidence: 92%
See 1 more Smart Citation
“…All primary CD34 þ CML cells were clearly shown to be TrkA positive (Figure 8b). In agreement with previous work (Bracci-Laudiero et al, 2003), CD34 þ cells from peripheral blood from healthy donors were stained weakly by TrkA-specific antibody (data not shown). We then performed a colony-forming assay in the presence of interleukin-3 (10 ng/ml) and granulocyte-macrophage colony-stimulating factor (20 ng/ml) with and without imatinib and/or NGF (50 or 200 ng/ml).…”
Section: Abl Tyrosine Kinase Downmodulates Trka Signalingsupporting
confidence: 92%
“…The difference may be explained by the fact that TrkAnegative cell lines, BV-173 and CML-T1 are CD34À and derived from patients in blast crisis, whereas all primary CD34 þ cells were derived from patients with CML in early chronic phase. In addition, CD34 þ cells from healthy donors also express TrkA (Bracci-Laudiero et al, 2003) and NGF is normally expressed by bone marrow stromal cells (Simone et al, 1999), suggesting that NGF plays a role in maintenance of CD34 þ cells Figure 4 Imatinib treatment restores TrkA-mediated phosphorylation of SHC. (a) The complex of CrkL with Bcr-Abl, GAB2 and SHIP2 in K562 cells is not detectable after imatinib treatment.…”
Section: Abl Tyrosine Kinase Downmodulates Trka Signalingmentioning
confidence: 99%
“…We postulate that the increased number of blood vessels in MSC/CD34 + grafts (assumingly allowing for greater blood flow to grafted areas) expedited the growth and development of peripheral nerves by providing key nerve-promoting factors. CD34 + HSPCs have also been shown to express a variety of neural proteins with an overlap of hematopoietic and neuropoietic molecular signatures including nerve growth factor, its receptor TrkA, and dopamine receptors DR3 and DR5 and also possess the ability to transdifferentiate into cells of neural lineage (30)(31)(32)(33). Dopamine has been determined to be a key molecule in neurite outgrowth, and its interaction with CD34 + HSPCs may have contributed to the peripheral nerve regeneration at the early time point of these experiments (34).…”
Section: Discussionmentioning
confidence: 99%
“…The mononuclear cord blood cells have been shown to express growth factors, such as nerve growth factor, 25 and some investigators have hypothesized the major role of endogenous neuroprotective factors in the HUCB-induced ischemic brain recovery. 26 Regardless of the mechanism of action, the clinical relevance of this HUCBC-based therapeutic option for ischemic stroke is obvious, although additional work is needed before use of HUCBC in the clinical setting.…”
Section: Discussionmentioning
confidence: 99%